These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299 [TBL] [Abstract][Full Text] [Related]
4. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619 [TBL] [Abstract][Full Text] [Related]
7. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function. Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000 [TBL] [Abstract][Full Text] [Related]
8. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy]. Narita M; Kurihara T J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697 [TBL] [Abstract][Full Text] [Related]
11. [The characteristics of 123I-MIBG myocardial scintigraphy in patients with left ventricular pressure-overload diseases]. Kobayashi H; Momose M; Niki K; Yamazumi R; Iguchi N; Inoue S; Horie T; Kusakabe K; Hosoda S Kaku Igaku; 1995 Jun; 32(6):587-92. PubMed ID: 7674569 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?]. Narita M; Kurihara T J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy]. Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy. Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine]. Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765 [TBL] [Abstract][Full Text] [Related]